Quality & complianceOfficial

Class II drug recall: Ranolazine Extended-Release Tablets (Ajanta Pharma Usa Inc)

🇺🇸 FDA enforcement report · Wed 07 Oct 2026

Failed Dissolution Specifications: below specification Recall D-0010-2027; status Ongoing; distribution: Nationwide in the US..

Official source: FDA enforcement report ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Quality & compliance All →